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In the vertebrate retina, the final step of visual chro-
mophore production is the oxidation of 11-cis-retinol to
11-cis-retinal. This reaction is catalyzed by 11-cis-retinol
dehydrogenases (11-cis-RDHs), prior to the chro-
mophore rejoining with the visual pigment apo-pro-
teins. The RDH5 gene encodes a dehydrogenase that is
responsible for the majority of RDH activity. In humans,
mutations in this gene are associated with fundus albi-
punctatus, a disease expressed by delayed dark adapta-
tion of both cones and rods. In this report, an animal
model for this disease, 11-cis-rdh/ mice, was used to
investigate the flow of retinoids after a bleach, and mi-
crosomal membranes from the retinal pigment epithe-
lium of these mice were employed to characterize re-
maining enzymatic activities oxidizing 11-cis-retinol.
Lack of 11-cis-RDH leads to an accumulation of cis-reti-
noids, particularly 13-cis-isomers. The analysis of 11-cis-
rdh/ mice showed that the RDH(s) responsible for the
production of 11-cis-retinal displays NADP-dependent
specificity toward 9-cis- and 11-cis-retinal but not 13-cis-
retinal. The lack of 13-cis-RDH activity could be a reason
why 13-cis-isomers accumulate in the retinal pigment
epithelium of 11-cis-rdh/ mice. Furthermore, our re-
sults provide detailed characterization of a mouse
model for the human disease fundus albipunctatus and
emphasize the importance of 11-cis-RDH in keeping the
balance between different components of the retinoid
cycle.
The production of 11-cis-retinal allows the regeneration of
visual pigments in the vertebrate retina (1), making it critical
for sustaining vision. One pathway involved in enzymatic pro-
duction of 11-cis-retinal, the retinoid cycle, is still not well
understood (2). What is known is that in this cycle, photoi-
somerized all-trans-retinal is reduced to all-trans-retinol by an
NADPH-specific all-trans-retinol dehydrogenase (all-trans-
RDH).1 After transport of all-trans-retinol from the rod outer
segments (ROS) to the retinal pigment epithelium (RPE),
isomerization to 11-cis-retinol occurs through either a mecha-
nism termed isomerohydrolase (3), a carbocation intermediate
(4), or an as yet unknown mechanism (reviewed in Ref. 2). In
the last step, the 11-cis-retinol product is oxidized to 11-cis-
retinal in a reaction catalyzed by 11-cis-RDH (Scheme 1) (5).
11-cis-RDH activity was reported to be membrane-associated
(6–8), and the main enzyme responsible for this reaction (11-
cis-RDH encoded by the RDH5 gene) was isolated by co-immu-
noprecipitation with RPE65, an abundant RPE protein (9),
believed to be essential for isomerization of all-trans-retinol to
11-cis-retinol (10, 11). Independently, 11-cis-RDH has been
cloned using antibodies against RPE proteins by Driessen et al.
(12). 11-cis-RDH has been identified as a member of the short-
chain alcohol dehydrogenase family. Those enzymes are in-
volved in redox reactions of such hydrophobic substances as
steroids, retinoids, and prostaglandins (13, 14). Members of
this family are characterized by molecular mass (300 amino
acids), a co-factor binding site (GXXXGXG), and a substrate
binding site (YXXXK) (13). They are often found as a dimer or
tetramer and usually contain hydrophobic N-terminal tails
thought to be involved in membrane anchoring. 11-cis-RDH is
largely found associated with smooth endoplasmic reticulum,
although some amount has also been found in the rough endo-
plasmic reticulum (15–17). The stereospecificity of 11-cis-RDH
has been shown to be pro-S-specific to both 11-cis-retinol and
NADH (18) and has the highest specificity for 11-cis-retinol,
followed by 13-cis-retinol and 9-cis-retinol (18, 19).
However, the question of additional functions of this enzyme
in the retinoid cycle has recently been raised. Mutations in the
RDH5 gene have been found in patients with fundus albipunc-
tatus, a disease characterized by profound delayed dark adap-
tation of cone and rod cells after a strong bleach (20). Despite
some of these mutations in the RDH5 gene resulting in inactive
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enzyme, patients harboring null mutations ultimately recover
their visual pigments. Therefore, 11-cis-retinal must be pro-
duced by alternative dehydrogenase-catalyzed oxidation of 11-
cis-retinol that compensates for the loss of RDH5 (18, 21, 22).
In accord with these results, transgenic mice missing the
RDH5 gene also display delayed dark adaptation, but only at
very high bleach levels (23). The molecular characterization of
this other dehydrogenase(s), however, has not yet been carried
out. A remarkable phenotype of 11-cis-rdh/ mice is the
accumulation of 11-cis-retinol/13-cis-retinol and 11-cis-retinyl/
13-cis-retinyl esters. This has led to the suggestion that 11-cis-
RDH could also be important in eliminating 13-cis-retinoids
from the RPE (23). Furthermore, the RDH5 gene has recently
been found widely expressed in non-ocular tissues (24–27). Due
to this wide expression, it has been hypothesized to catalyze the
oxidation of 9-cis-retinol in tissues in which 11-cis-retinoids are
not present. It is also worth noting that the expression levels
are much lower in these tissues compared with the RPE, yet
11-cis-RDH has not been detected by immunocytochemistry in
cells of the retina other than RPE using both polyclonal (22)
and monoclonal2 antibodies. This observation, in conjunction
with the fundus albipunctatus phenotype, suggests that the
11-cis-RDH present in the RPE is involved in the production of
11-cis-retinal for both rod and cone cells. 11-cis-RDH could be
also important for the photochemical production of 11-cis-retinal
from all-trans-retinal by the retinal G protein-coupled receptor
(RGR) of RPE and Müller cells (28, 29). Recently, Fong and
co-workers (30) have shown that 11-cis-RDH co-purifies with
RGR. The possible role 11-cis-RDH plays in this complex could be
the reduction of 11-cis-retinal to 11-cis-retinol, which is stored in
a form of 11-cis-retinyl esters.
In this study, we investigated the effects of age and light
conditions on 11-cis- and 13-cis-retinoid accumulations in 11-
cis-rdh/ mice. We then evaluated the flow of retinoids in
the eyes of these mice after an intense bleach. Isolated RPE
membranes from 11-cis-rdh/ mice were used to investigate
the presence of an alternative oxidation enzyme(s), stereospec-
ificity and isomeric retinoid preference, and the effect of the
lack of 11-cis-RDH on the isomerization reaction. These studies
revealed potential mechanisms by which 13-cis-retinol is pro-
duced and provide an extensive characterization of an alterna-
tive dehydrogenase enzyme responsible for 11-cis-retinal
production.
MATERIALS AND METHODS
11-cis-rdh Mice—All animal experiments were approved by the Uni-
versity of Washington Animal Care Committee and conformed to the
recommendations made by the American Veterinary Medical Associa-
tion Panel on Euthanasia. The animals were maintained under a 24-h
dark and/or 12-h light-dark cycle. All manipulations were performed
under dim red light employing a Kodak No. 1 safelight filter (transmit-
tance, 560 nm). 11-cis-rdh/ mice were derived from a 129/Sv em-
bryonic stem cell line generated by homologous recombination with a
targeting vector that eliminated exons I, II, and III (23). Chimeric male
mice were mated with C57BL/6 females and maintained as a recombi-
nant inbred line. Progeny of matings were genotyped by RDH5-specific
primers and polymerase chain reaction (23). Typically, 1–2-month-old
mice were used in all experimental procedures. All procedures were
performed as described previously (31).
Retinoid Extraction and Analysis—All procedures were performed
under dim red light as described previously (11, 23, 31, 32). In addition
to previously described methods, retinoid analysis was performed on an
HP1100 liquid chromatograph equipped with a diode array detector and
HP Chemstation (A.07.01) software, allowing identification of retinoid
isomers according to their specific retention times and absorption max-
ima. A normal-phase column (Beckman Ultrasphere Si 5 , 4.6  250
mm) and an isocratic solvent system of 0.5% ethyl acetate in hexane
(v/v) for 15 min followed by 4% ethyl acetate in hexane for 60 min at a
flow rate of 1.4 ml/min (total, 75 min) with detection at 325 nm allowed
the separation of 11-cis-retinyl esters, 13-cis-retinyl esters, and all-
trans-retinyl esters at 20 °C.
Preparation of Retinyl Palmitates—Retinols (1 mol) were dissolved
in dry dichloromethane (dried and distilled over CaH2) (5 ml), and 3
mol of diisopropylethylamine and 2 mol of palmitoyl chloride (Al-
drich/Sigma) were added to the reaction mixture, which was kept on ice
for 24 h with occasional shaking. The reaction mixture was washed with
3  5 ml of water, 5 ml of saturated Na2CO3, and was dried with
anhydrous MgSO4. Organic solvent was dried under a stream of argon,
and esters were dissolved in hexane and purified employing HPLC.
Preparation of Mouse RPE Microsomes—Fresh mouse eyes were
enucleated immediately after either cervical dislocation or CO2 asphyx-
iation. Typically 30–40 eyes were dissected for each preparation. The
anterior segment, vitreous, and retina were carefully removed by mi-
crodissection. RPE cells were separated by placing 12 dissected eyecups
in 400 l of 10 mM MOPS, pH 7.0, 250 mM sucrose, 1 mM dithiothreitol,
and 1 M leupeptin with vigorous shaking for 20 min. The eyecups were
then gently brushed with a fine brush to further dislodge RPE cells. The
cell suspension was removed, another aliquot of 400 l of MOPS buffer
was added, and the eyecups were shaken again for 20 min at room
temperature. The cell suspensions were combined and subjected to
glass-glass homogenization. The homogenate was centrifuged at
10,000  g for 10 min, and then the supernatant was centrifuged at
275,000  g for 1 h. The pellet was reconstituted in 200 l of 10 mM
MOPS, pH 7.0, 1 mM dithiothreitol, and 1 M leupeptin and homoge-
nized (glass-glass) again. The protein concentration (typically 0.5–1
mg/ml) was determined using the Bradford method (33).
Preparation of Pro-S-[4-3H]NADH, Pro-R-[4-3H]NADPH, and Pro-S-
[4-3H]NADPH—Syntheses of pro-S-[4-3H]NADH and pro-S-[4-
3H]NADPH were carried out with L-glutamic dehydrogenase (Sigma),
NAD, and NADP (Sigma), respectively, and L-[2,3-3H]glutamic acid
(PerkinElmer Life Sciences) as described previously (22). Synthesis of
pro-R-[4-3H]NADPH was prepared from [4-3H]NADP and L-glutamic
acid, employing L-glutamic dehydrogenase (18).
Preparation of Pro-R-[4-3H]NADH—The preparation of pro-R-[4-
3H]NADH was accomplished by utilizing the pro-R-specific yeast alco-
hol dehydrogenase (Sigma) to reduce NAD with [1-3H]EtOH (ARC).
Yeast alcohol dehydrogenase (1.5 mg in 1.2 ml of 25 mM bis-tris-pro-
pane, pH 8.8, 0.1% bovine serum albumin) was mixed with NAD (14
mol in 70 l of H2O) and [1-
3H]EtOH (100 mCi/mmol, 0.25 mCi in 250
l of H2O), and the mixture was incubated at room temperature for 45
min. The reaction was stopped by addition of 1.5 ml of MeOH, and the
resulting mixture was dried in a Speedvac. The residue was dissolved in
700 l of H2O, flash-frozen with liquid nitrogen, and again dried in the
Speedvac. This was repeated once more to ensure the complete removal
of residual [1-3H]EtOH. The product was purified on a Mono Q HR 5/5
column (Amersham Pharmacia Biotech) equilibrated with 10 mM bis-
tris-propane, pH 7.3, using a linear gradient of 0–500 mM NaCl over 60
min at a flow rate of 1 ml/min. Concentrations of NADH and NADPH
(pH 7.4) were determined using   6220 at 340 nm, and concentrations
of NAD and NADP (pH 7.4) were determined using   18,000 at 260
nm (34). [4-3H]NADH and [4-3H]NADPH (100–250 M) were stored at
–20 or 80 °C in their original elution buffers.
RDH Assays for Mouse RPE Microsomes—Activities of RDH in RPE
microsomes of 11-cis-rdh/ and 11-cis-rdh–/– mice were assayed by2 K. Palczewski, unpublished data.
SCHEME 1. Redox reactions catalyzed by mouse 11-cis-RDH. 11-cis-RDH is a NAD-specific enzyme, whereas other enzymes in the RPE
utilize NADP to produce 11-cis-retinal, which is transported to ROS to regenerate rhodopsin.
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monitoring the production of [15-3H]retinol (reduction of retinal) (18).
The reduction reaction mixture (100 l) contained MES (final concen-
trations, 62–66 mM, pH 5.5), dithiothreitol (1 mM), pro-R (or pro-S)-[4-
3H]NADH (21 M) or pro-R (or pro-S)-[4-3H]NADPH (21 M), 11-cis-
rdh/ (2.2–3.8 g) or 11-cis-rdh/ (3.2–5.4 g) mice RPE
microsomes in the presence or absence of NAD(P)H (420 M), and 2 l
of retinal (132 M) substrate stock was added last to initiate the reac-
tion. The reaction was incubated at 34–37 °C for 50 min and then
terminated with 400 l of methanol, 100 l of 1 M NaCl and extracted
with 500 l of hexane. Radioactivity was measured in 400 l of the
organic phase by scintillation counting. In some cases, 400 l of the
upper phase was removed and dried down by a stream of argon or by
Speedvac. The residue was dissolved in 120 l of hexane, and 100 l of
the hexane solution was analyzed by HPLC using 10% ethyl acetate in
hexane to confirm the formation of the corresponding retinol. The
retinol fractions were collected and subjected to scintillation counting.
RDH Assays for Bovine RPE Cytosol—Bovine RPE cytosol was pre-
pared as described previously (35). The resulting cytosol was adjusted
with CaCl2 and MgCl2 (final concentration of both, 1 mM) and centri-
fuged at 146,000  g for 50 min. The supernatant was then filtered
through a 0.22 m Millex-GV filter (Millipore), and 30 l (1.32 g/l) of
the filtrate was used for RDH assays as described above.
Isomerization of All-trans-retinol to 11-cis-retinol Using Mouse RPE
Microsomes—The assay used for determining isomerization to 11-cis-
retinol was reported previously (35–37). Briefly, the reaction mixture,
containing 1% bovine serum albumin, 30 mM bis-tris-propane, pH 7.5, 1
mM ATP, 15 M apo-rCRALBP, 40 l of mouse RPE (typically 20–40
g of total protein), and 10 M all-trans-retinol (in dimethylformamide),
was incubated for 2 h at 37 °C. The reaction was quenched using 300 l
of MeOH, and retinoids were extracted with 200 l of hexane. The
mixture was shaken vigorously for 2 min and then centrifuged at 14,000
rpm for 4 min for phase separation. The upper organic layer was
removed, and an aliquot of 100 l was analyzed by HPLC using 10%
ethyl acetate in hexane.
RESULTS
Separation of Retinoids—To analyze the retinoid flow in
11-cis-rdh mice, and for the biochemical assays used in this
study, retinoids were separated using two chromatographic
conditions. In the first system, the concentration of the modi-
fier solvent, ethyl acetate, was initially set at 0.5% in hexane to
separate 13-cis-, 11-cis-, and all-trans-retinyl esters and then
increased to 4% in hexane (Fig. 1). The separation of 13-cis-
from 11-cis-retinyl esters was particularly challenging, and
only partial separation of these esters was accomplished (iden-
tified by characteristic UV/visible spectra). 11-cis-Retinol and
13-cis-retinol could not be separated by employing this system
given that both retinols always co-elute, whereas all other
retinoids were separated to baseline. Partial separation of
11-cis-retinol and 13-cis-retinol was accomplished using an
isocratic elution system of 10% ethyl acetate in hexane, as
discussed below. In addition, all retinoids were identified by
co-elution with authentic retinoids and in many cases by mass
spectrometry. With this separation technique, we analyzed
changes in retinoid concentration in vivo using 11-cis-rdh/
mice and 11-cis-rdh/ mice as controls.
Retinoids in 11-cis-rdh Mice—Previous analysis of retinoids
in 11-cis-rdh/ mice revealed a high accumulation of cis-
retinyl esters as compared with 11-cis-rdh/ mice, whereas
11-cis-rdh/– mice showed intermediate characteristics (23).
The ester hydrolysis of cis-retinyl esters, however, introduced
uncontrollable spontaneous isomerization of retinoids. In this
study, we used 1–2-month-old animals reared under 24-h dark
and/or 12-h light-dark cycle. HPLC separation profiles of 11-
cis-rdh/ and 11-cis-rdh/ mice are presented in Fig. 2. In
the eyes of 11-cis-rdh/ mice, retinyl ester concentration
increased 4.2-fold compared with 11-cis-rdh/ mice. One-
month-old 11-cis-rdh/ mice contained prominently higher
concentrations of 13-cis-retinyl esters and 11-cis-retinyl esters
(Fig. 2). This result was in agreement with previous studies
(23). For 11-cis-rdh/ mice, only a minimally elevated ab-
sorption was observed in the region that corresponds to cis-
retinyl esters. Such minimal peaks and the breakthrough of the
column raised uncertainty about the origin of this absorption.
However, if these peaks are indeed cis-retinyl esters, they are
in trace amounts compared with all-trans-retinyl esters. For
further identification, the cis-retinyl ester peaks from 11-cis-
rdh/ mice were collected and chemically isomerized using
I2. This resulted in the decrease in cis-retinyl esters and pro-
duction of all-trans-retinyl and 13-cis-retinyl esters in our ex-
perimental conditions in a ratio of 3:1, respectively (Fig. 2,
inset). Hence, 15% of the cis-retinyl esters in 11-cis-rdh/
FIG. 1. Chromatograms for separation of retinyl palmitate, retinal oxime, and retinol standards. Peak 1, 13-cis-retinyl palmitate; peak
2, 11-cis-retinyl palmitate; peak 3, all-trans-retinyl palmitate; peak 4, syn-11-cis-retinal oxime; peak 5, syn-all-trans-retinal oxime; peak 6,
syn-9-cis-retinal oxime; peak 7, anti-11-cis-retinal oxime; peak 8, anti-9-cis-retinal oxime; peak 9, anti-all-trans-retinal oxime; peak 10, 11-cis-
retinol; peak 11, 9-cis-retinol; peak 12, all-trans-retinol. Insets, UV/visible spectra of peaks 1, 2, and 3.
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mice are present as 11-cis-retinyl esters. No significant
amounts of free retinols were observed in fresh samples, as
compared with the previous studies. This could be a result of
longer time periods between eye dissection and analysis in the
original studies.
The Effect of Light and Age on the Accumulation of cis-
Retinyl Esters—The question arose whether the formation of
cis-retinyl-esters is dependent on age and exposure of eyes to
light. Therefore, three groups of 11-cis-rdh/ mice were
reared under different light regimens. The first group was
reared under a 12-h light-dark cycle. HPLC retinoid analysis
confirmed that under these conditions, 11-cis-rdh/ mice
stored their esters predominantly in the cis-retinyl conforma-
tion (Fig. 3A). Retinoid analysis of the second group, reared
under 24-h dark, also showed the presence of retinyl esters
predominantly in the cis-retinyl conformation. The third group,
reared under 24-h dark, but exposed to seven light flashes
(each bleaching 40% of rhodopsin) and subsequently dark-
adapted for 12 h also had a high concentration of cis-retinyl
esters present in the posterior pole of the eye. Representative
chromatograms are presented in Fig. 3A. No differences were
observed compared with control 11-cis-rdh/ mice reared
under 24-h dark and/or a 12-h light-dark cycle (results not
shown). Hence, exposure to light does not influence the retinyl
ester conformation in 11-cis-rdh/ mice.
To investigate the effect of age on the accumulation of cis-
retinyl esters, 2-week-old, 3-month-old (Fig. 3B), and 6-month-
old mice were tested. For 2-week-old 11-cis-rdh/ mice,
300 pmol of rhodopsin was produced, compared with 500–
600 pmol for adult mice. No 11-cis-retinyl ester and very low
amounts of all-trans-retinyl ester were observed, whereas 13-
cis-retinyl ester was very prominent. For the 2-month-old and
older mice, an increase in total amount of esters was apparent;
however, a similar ratio between 13-cis-, 11-cis-, and all-trans-
retinyl esters was observed (discussed below). Because these
measurements were taken at one time point, it was important
to look at the flow of retinoids immediately after intense
bleaching.
Kinetics of the Retinoid Flow in 11-cis-rdh Mice Post-
bleach—To test the flow of retinoids after an intense bleach,
1-month-old 11-cis-rdh/ and 11-cis-rdh/ mice were
used. Mice were dark-adapted for 12 h and exposed to a flash
that bleached 40% of their visual pigment. Immediately after
the flash, mice were transferred to the dark and sacrificed at
different times; their eyes were then enucleated. The amount of
11-cis-retinal decreased from 400 pmol/eye to 250 pmol/eye
immediately after the flash, whereas the amount of all-trans-
retinal increased from 5 to 150 pmol/eye (Fig. 4, e and a,
respectively). The rate of reduction of all-trans-retinal in ROS
of 11-cis-rdh/ mice was identical to that in ROS of 11-cis-
rdh/ mice, and statistically, no differences were observed in
free all-trans-retinol (Fig. 4). Retinyl esters were significantly
FIG. 2. HPLC separation of retinoids for 1-month-old 11-cis-rdh mice. A, 11-cis-rdh/ reared under 12-h light-dark cycle. Inset, chemical
isomerization of collected 11-cis- and 13-cis-retinyl esters employing I2 (see under “Materials and Methods”). Peak 1, 13-cis-retinyl ester; peak 2,
11-cis-retinyl ester; peak 3, all-trans-retinyl ester; peak 4, syn-11-cis-retinal oxime; syn-all-trans-retinal oxime; peak 7, anti-11-cis-retinal oxime.
B, 11-cis-rdh/ reared under 12-h light-dark cycle.
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elevated (2–3-fold) in 11-cis-rdh/ mice, with the most no-
ticeable difference being a higher concentration of cis-retinyl
esters (10% in 11-cis-configuration, 60% in 13-cis-configu-
ration, and the rest as all-trans-retinyl esters) (Fig. 5). It ap-
pears that the higher concentration of esters could be ac-
counted for by extra cis-esters, compared with 11-cis-rdh/
mice, the ester concentrations of which did not significantly
fluctuate during dark adaptation after intense flash. Only
slightly higher concentrations of cis-retinols were observed in
11-cis-rdh/ mice as compared with 11-cis-rdh/ mice after
the bleaching and subsequent dark recovery, indicating that an
alternative 11-cis-RDH is less efficient in oxidizing 11-cis-ret-
inol to 11-cis-retinal. Most importantly, the recovery of 11-cis-
retinal was indistinguishable between 11-cis-rdh/ mice and
11-cis-rdh/ mice (Fig. 4). These results suggest that other
enzymes, in addition to 11-cis-RDH, are responsible for the
oxidation of 11-cis-retinol. Further characterization of this ac-
tivity was necessary.
Stereospecificity and Isomeric Preference of an Alternative
RDH Activity Present in RPE Microsomes of 11-cis-rdh–/–
Mice—Mouse RPE microsomes from 11-cis-rdh/ mice were
used to establish isomeric preference and specificity of an al-
ternative enzyme activity responsible for the production of
11-cis-retinal. Because the redox reactions are readily reversi-
ble, we used the reduction of retinals to retinols with radioac-
tive dinucleotides in our assays, employing phase partition to
separate the radioactive product (e.g. reduction of 11-cis-retinal
to [15-3H]11-cis-retinol) from the excess of radioactive dinucle-
otide substrate (38). The assay was independently verified by
HPLC separation of retinoid substrates and products. Studies
have shown that 11-cis-RDH has a higher affinity for 11-cis-
retinal and 13-cis-retinal than for 9-cis-retinal and all-trans-
retinal (18). In stereospecific assays, 11-cis-RDH uses pro-S-[4-
3H]NADH to yield pro-S-[15-3H]11-cis-retinol; hence, 11-cis-
RDH displays dual pro-S stereospecificity. We tested pro-S-[4-
3H]NADPH nucleotide substrate. For both 11-cis-rdh/ and
11-cis-rdh/ mice, no differences were found when pro-S-[4-
3H]NADPH and all-trans-retinal in the presence or absence of
excess NADH was used. Incubation with pro-S-[4-3H]NADPH
and all-trans-retinal in the absence of excess NADH resulted in
2.1 and 4.6 nmol/min/mg [3H]retinol, whereas in the presence
of excess NADH, no inhibition of [3H]retinol production was
found (Fig. 6). This could result from undefined amounts of
ROS membrane contamination containing pro-S-NADPH-spe-
cific all-trans-RDH (18, 39). Highly purified ROS membranes
do not have cis-RDH activity, so all measured cis-RDH activity
in our microsomal RPE fractions was derived from the RPE.
Incubation of RPE protein fractions of 11-cis-rdh/ mice using
pro-S-[4-3H]NADPH with 9-cis-retinal or 11-cis-retinal produced
0.3 nmol/min/mg [15-3H]9-cis-retinol or 0.2 nmol/min/mg [15-
3H]11-cis-retinol (confirmed by HPLC), respectively. In contrast,
incubation of RPE protein fractions of 11-cis-rdh/ mice with
pro-S-[4-3H]NADPH and 13-cis-retinal produced very little
(0.01 nmol/min/mg), if any, [15-3H]13-cis-retinol. NADH was a
poor substrate for 11-cis-rdh/ RPE microsomal proteins, as
was determined by direct assay with radioactive [3H]NADH and
FIG. 3. HPLC separation of retinoids
for 2-month-old 11-cis-rdh mice. A,
11-cis-rdh/ reared under 24-h dark and
exposed to seven flashes, each of which
bleached 40% of rhodopsin, at 1-h inter-
vals and subsequently dark-adapted for 12 h
(top trace); 11-cis-rdh/ reared under 24-h
dark (middle trace); 11-cis-rdh/ reared
under a 12-h light-dark cycle and dark-
adapted for 12 h (bottom trace). Peak 1, 13-
cis-retinyl ester; peak 2, 11-cis-retinyl ester;
peak 3, all-trans-retinyl ester; B, 14-day-
old 11-cis-rdh/ (top panel) and 3-month-
old 11-cis-rdh/ reared under 24-h dark
(bottom panel).
FIG. 4. Kinetics of retinoid recovery
in 11-cis-rdh/ and 11-cis-rdh/
mice. Mice were reared under 12-h light-
dark cycle. HPLC retinoid analysis was
either before or after a flash that bleached
40% of the visual pigment. Photolyzed
rhodopsin released all-trans-retinal (a),
which was reduced to all-trans-retinol (b)
and then transported to the RPE and es-
terified to retinyl esters (c). All-trans-ret-
inol, or its derivative, was isomerized to
11-cis-retinol (d), which in turn, was oxi-
dized to 11-cis-retinal (e). Closed circles
represent 11-cis-rdh/ mice. The gray
line represents data obtained from 11-cis-
rdh/ mice. Error bars indicate the
standard error of the mean (n  3).
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by lack of inhibition of the [3H]NADPH-dependent reaction with
cold excess of NADH (Fig. 6). RPE protein fractions of 11-cis-
rdh/ mice assayed with pro-S-[4-3H]NADH and 9-cis-retinal,
11-cis-retinal, or 13-cis-retinal in the presence or absence of ex-
cess NADPH resulted in the formation of 0.1 nmol/min/mg
[3H]retinol. Incubating RPE protein fractions of wild-type mice
with pro-S-[4-3H]NADH and 9-cis-retinal, 11-cis-retinal, or 13-
cis-retinal in the absence of excess NADPH, on the contrary,
resulted in the formation of 1.2, 1.1, and 1.5 nmol/min/mg
[3H]retinol, respectively, whereas with pro-S-[4-3H]NADPH,
[3H]retinol production was much lower. Therefore, NADH-de-
pendent reduction of 11-cis-retinal and 9-cis-retinal was signifi-
cantly decreased in the RPE membranes from 11-cis-rdh/
mice.
Incubation of RPE protein fractions of 11-cis-rdh/ mice
with pro-R-[4-3H]NADPH and 9-cis-retinal, 11-cis-retinal, or
13-cis-retinal in the absence of excess NADH resulted in 0.01
nmol/min/mg [3H]retinol, whereas in the presence of excess
NADH, [3H]retinol production seemed to be less. When RPE
protein fractions of 11-cis-rdh/ mice were assayed with
pro-R-[4-3H]NADH and 9-cis-retinal, 11-cis-retinal, or 13-cis-
retinal in the presence or absence of excess NADPH,  0.1
nmol/min/mg [3H]retinol was formed, whereas in 11-cis-
rdh/ mice only 0.05, 0.013, and 0.03 nmol/min/mg [3H]reti-
nol was obtained. Hence, pro-R-NADPH and pro-R-NADH ac-
tivities were 10 times lower (Fig. 7) in both 11-cis-rdh/
and 11-cis-rdh/ mice, suggesting that no pro-R-specific en-
zyme is responsible for the alternative 11-cis-RDH activity. In
conclusion, when using RPE protein fractions from 11-cis-
rdh/ mice, 11-cis-retinal reduction was most efficient using
pro-S-[4-3H]NADPH, resulting in 0.2 nmol/min/mg [3H]reti-
nol production, which is less efficient compared with RPE pro-
tein fractions of wild-type mice with pro-S-[4-3H]NADH and
11-cis-retinal, resulting in 1.1 nmol/min/mg [3H]retinol.
In addition, we tested bovine RPE for possible soluble RDH
activity. A bovine soluble RPE protein preparation was used
because larger and more concentrated preparations could be
obtained. Only very residual activity was found (Fig. 8), which
cannot account for the alternative oxidation of retinols.
Isomerization of All-trans-retinol to cis-Retinols in RPE
Membranes from 11-cis-rdh / Mice—As mentioned in the
Introduction, 11-cis-RDH was first identified by immunopre-
cipitation with RPE65, a protein thought to be involved in the
isomerization of all-trans retinol to 11-cis-retinol. This sug-
FIG. 5. Kinetics of retinyl esters in 11-cis-rdh/ mice. Mice
were reared under 12-h light-dark cycle. HPLC retinoid analysis was
either before or after a flash that bleached 40% of the visual pigment.
Note the scaling on the y axis. Error bars indicate the standard error of
the mean (n  3).
FIG. 6. Relative RDH activity in the
RPE of 11-cis-rdh/ and 11-cis-rdh/
mice with pro-S-[4-3H]NAD(P)H and
geometric isomers of retinals. The assay
was carried out for 50 min at 34–37 °C
using the phase partition assay as de-
scribed under “Materials and Methods.”
All-trans-retinal (A), 11-cis-retinal (B),
9-cis-retinal (C), and 13-cis-retinal (D)
were used as substrates. Indicated is the
amount of the corresponding [3H]retinol
isomer formed (confirmed by HPLC; see
under “Materials and Methods”) in nmol/
min/mg of protein.
Oxidation of 11-cis-Retinol in the Vertebrate Retina 32461
gested that 11-cis-RDH might closely interact with the pro-
tein(s) that catalyzes isomerization. It was therefore important
to determine whether isomerization is affected in the RPE
microsomes of 11-cis-rdh/ mice. We adapted an isomerase
assay, described previously, (35–37) for bovine RPE, to meas-
ure the isomerase activity in mouse RPE microsomes. After
isolating RPE microsomes from mice, isomerization was per-
formed in the presence of CRALBP according to previously
published procedures (35–37). The results showed that, indeed,
isomerization to 11-cis-retinol still takes place in the RPE
microsomes of 11-cis-rdh/ mice; however, the data obtained
furthermore suggest that isomerization occurs at a reduced
rate in 11-cis-rdh/ mice compared with 11-cis-rdh/ mice
(Fig. 9).
DISCUSSION
Accumulation of 11-cis-Retinyl Esters in 11-cis-rdh/
mice—Accumulation of 13-cis-retinoids in RPE of 11-cis-
rdh/ mice is, to our knowledge, the first example of a
significant presence of this isomer in the vertebrate system. A
low difference in free energy between all-trans-retinol and 13-
cis-retinol (G  1 kcal) leads to spontaneous formation of
13-cis-retinol, and therefore, trace amounts of 13-cis-retinoids
are frequently found in all biological samples in which all-
trans-retinoids are present. In 11-cis-rdh/ mice, the phe-
nomenon is different because there is a highly significant ac-
cumulation of 13-cis-retinyl esters (100 pmol/eye) in the RPE, a
much higher level than the trace amounts observed in 11-cis-
rdh/ mice (5 pmol) (Fig. 2). 11-cis-rdh/ mice also accu-
mulate significant amounts of 11-cis-retinyl esters (30–50
pmol/eye), which are present only in trace amounts in 11-cis-
rdh/ mice. This accumulation does not consequently results
from light conditions to which these 11-cis-rdh/ animals were
exposed to (Fig. 3), suggesting that some thermodynamic equi-
librium governs this process and that 11-cis-retinol is not derived
from a default pathway during the regeneration of photoisomer-
ized chromophore but rather from a constitutive activity of RPE
in 11-cis-rdh/ mice. We could not exclude the possibility that
in vivo spontaneous isomerization occurs. This could be due to an
accumulation of all-trans-retinol. However, in another set of ex-
periments, we looked at the accumulation of cis-retinoids as a
function of age. 13-cis-Retinyl esters were present in all tested
ages from 14 days to 6 months. Only in very young mice (14 days
old) were 11-cis-retinyl esters absent (Fig. 3B, top). Spontaneous
FIG. 7. Relative RDH activity in the
RPE of 11-cis-rdh/ and 11-cis-rdh/
mice with pro-R-[4-3H]NAD(P)H and
geometric isomers of retinals. The assay
was carried out for 50 min at 34–37 °C using
the phase partition assay as described un-
der “Materials and Methods.” All-trans-ret-
inal (A), 11-cis-retinal (B), 9-cis-retinal (C),
and 13-cis-retinal (D) were used as sub-
strates. Indicated is the amount of the cor-
responding [3H]]retinol isomer formed in
nmol/min/mg of protein.
FIG. 8. Relative RDH activity in the cytosol of bovine RPE with
pro-R-[4-3H]NAD(P)H or pro-S-[4-3H]NAD(P)H and geometric
isomers of retinals. The assay was carried out for 40 min at 33–37 °C
using the phase partition assay as described under “Materials and
Methods.” A, pro-R-[4-3H]NAD(P)H. B, pro-S-[4-3H]NAD(P)H. Indi-
cated is the amount of the corresponding [3H]]retinol isomer formed in
nmol/min/mg of protein.
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in vivo formation of 13-cis-retinoids is very unlikely in these
animals because only trace amounts of all-trans-retinoids are
present. Another argument against the idea of spontaneous
isomerization is the fact that in mice with a targeted disruption
of the RPE65 gene, a huge accumulation of all-trans-retinyl es-
ters does not lead to formation of 13-cis-retinyl esters in vivo and
in vitro (11). Around 14 days after birth, rhodopsin is produced at
a very high rate, as ROSs elongate and 50–75% of the adult
rhodopsin content is present (data not shown). It is possible that
11-cis-retinyl esters are quickly hydrolyzed and used to regener-
ate newly synthesized rhodopsin. With aging, when the synthesis
of rhodopsin is balanced by phagocytosis, a large fraction of the
chromophore bound to opsin is recycled; thus, the demand for de
novo synthesis of 11-cis-retinal is lowered. In adult 11-cis-rdh
mice, the production of 11-cis-isomer keeps up with the demand
for this isomer, because the rate of rhodopsin regeneration is
unaffected in these animals (23) (Fig. 4e).
In previous studies, formation of 13-cis-retinol was observed
in dissected eyes (23). In dark-adapted animals, using freshly
dissected eyes, we were not able to observe this retinoid in
significant amounts. Therefore, it is possible that 13-cis-retinol
observed in the previous studies was a result of hydrolysis of
the esters during the processing of these samples. Lack of
accumulation of cis-retinols could be explained by low affinity
of retinoid-binding proteins to retinols as compared with alde-
hydes (40) and powerful lecithin:retinol acyl transferase activ-
ity in RPE (35, 37, 41). After bleaching, there is a 30%
elevation of cis-retinols (Fig. 4d), most likely resulting from
lowered oxidation capacity of 11-cis-rdh/ RPE membranes,
before rhodopsin is fully regenerated, retinols are re-esterified,
and normal cis-retinol concentrations are re-established again.
Utilization of cis-Retinyl Esters—Isomerization of all-trans-
retinol to 11-cis-retinol requires G  4 kcal (2). One model
concerning the isomerization step in the retinoid cycle assumes
that the hydrolysis of retinyl esters provide the excess energy
necessary for the isomerization process (42, 43). It has been
hypothesized that potent inhibition by cis-retinols prevents
isomerization of all-trans-retinyl esters (44). This model is,
however, inadequate to explain the formation of cis-retinoids in
RPE of 11-cis-rdh/ mice (Fig. 2); thus, other models that
would explain this perturbed isomerization system by lack of
11-cis-RDH should be considered.
McBee et al. have proposed that light provides the input of
energy for both formation of MII and rhodopsin regeneration.
The action of light is a two-step process: first, energy (35
kcal/mol) (reviewed in Ref. 2) is absorbed by the chromophore-
opsin complex, allowing consequent changes in the rhodopsin
conformation and the hydrolysis of the photoisomerized chro-
mophore all-trans-retinal; second, exothermic formation of rho-
dopsin from opsin and 11-cis-retinal is regenerated through the
retinoid cycle (10 kcal/mol). Re-formation of rhodopsin would
allow the unfavorable isomerization reaction to overcome the
needed G  4 kcal/mol by moving retinoids from one step of
the reaction to another by mass action. Binding of 11-cis-retinal
to CRALBP would drive the isomerization/oxidation process,
providing 8–10 kcal/mol based on the relation between G and
Kd. A lack of acceptor for the isomerization process would halt
isomerization observed in RPE microsomes (35). This explana-
tion is also consistent with the observation that when CRALBP
is replaced with cellular retinol-binding protein, a retinoid-
binding protein with different specificities, enzymatic forma-
tion of 13-cis-retinol was observed (4). In 11-cis-rdh/ mice,
inefficient oxidation could perturb the isomerization system,
leading to accumulation of 13-cis-retinoids, as dictated in vivo
by equilibrium constants between binding proteins, slower ox-
idation, and lecithin:retinol acyl transferase and hydrolase ac-
tivities toward different isomers. It is unclear from our studies
whether 13-cis-retinyl esters could be utilized for the conver-
sion to 11-cis-retinol/retinal. Most likely, double isomerization
around C 13 to form the trans-configuration around this bond
and C 11 to form the cis-configuration around this bond would
not be energetically feasible. Therefore, we favor the idea that
all-trans-retinyl-esters, through an as yet unconfirmed inter-
mediate (a carbocation intermediate has been postulated in the
most recent studies (4)), is the substrate for further formation
of 11-cis-retinol.
Other transgenic animals in which genes encoding proteins
thought to play a role in the retinoid cycle are disrupted include
CRALBP (45), cellular retinol-binding protein type 1 (CRBPI)
(46), ABCR (47), interphotoreceptor retinoid-binding protein
(IRBP) (31, 48, 49), and RPE65 (10) knockout mice (reviewed in
Ref. 50). In addition to 11-cis-rdh/ mice, ABCR and
CRALBP knockout mice were reported to have delayed dark
adaptation. Recently, more compelling evidence has emerged
indicating that mutations in some of the genes encoding pro-
teins with a function in the retinoid cycle result in a more
severe retinal pathology in humans compared with mice. For
example, in abcr/ mice that are lacking ABCR (which is
believed to function as an outwardly directed flippase for N-
retinylidene-PE (51, 52)), no RPE cell enlargement or degener-
ation, as is evident in advanced Stargardt’s disease, was pres-
ent. Furthermore, photoreceptor degeneration developed
slowly in abcr/ mice. Another example is cralbp/ mice,
which show little or no reduction in the number of photorecep-
tor cells, whereas mutations in the CRALBP gene in humans
are found to be associated with autosomal recessive retinitis
pigmentosa and retinitis punctata albescens (53–55). Finally,
11-cis-rdh/ mice display normal dark adaptation kinetics
FIG. 9. Isomerization to 11-cis-retinol remains active in 11-cis-
rdh/ mice. Mouse RPE microsomes were prepared as described
under “Materials and Methods.” Approximately 20–40 g of protein (40
l) was added to a solution of 1% bovine serum albumin, 1 mM ATP, 15
M apo-rCRALBP, and 50 mM bis-tris-propane, pH 7.5, to a final volume
of 220 l. The reaction was incubated by addition of 0.5 l of all-trans-
retinol in dimethylformamide (4 mM stock) for 2 h at 37 °C. Retinoids
were extracted through addition of 300 l of MeOH and 200 l of
hexane and analyzed by HPLC, as described under “Materials and
Methods.” Arrows 1 and 2 indicate elution of 11-cis-retinol and 13-cis-
retinol, respectively. The top trace shows reduced production of 11-cis-
retinol in 11-cis-rdh/ mice under identical conditions compared
with 11-cis-rdh/ mice RPE (bottom trace).
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at bleaching levels under which patients suffering from fundus
albipunctatus display slower dark adaptation. Additionally, in
the fundus of 11-cis-rdh/ mice, no punctata typical for
fundus albipunctatus are present. A question arises as to what
causes the more severe outcome for humans. One theory sug-
gests that complete absence of proteins, which is the case in
most mouse knockout models, is less deleterious than the con-
tinual production of mutant proteins, which can be toxic, as is
the case in most human cases. Another explanation might be
that, contrary to humans, mice are night animals with eyes
adapted to dim light vision in which the compensatory mech-
anisms may be much more evolved than in humans, resulting
in less pronounced retinal pathology. Further research is
needed to explore this possibility.
11-cis-rdh/ Mice: A Model for Human Fundus Albipunc-
tatus—Mutations in the RDH5 gene in humans have been
associated with a night blindness disease called fundus albi-
punctatus (56). Several mutations have been identified (20–22,
57–61), and longer follow-ups of the progress of the disease and
more careful electroretinogram testing have showed that the
disease is not stationary as originally thought; instead, these
studies show a slow deterioration of vision and photoreceptor
degeneration (60).
Recently, we extensively studied the consequences of a lack
of 11-cis-RDH in a family with fundus albipunctatus. An Arg-
157 to Trp mutation in the RDH5 gene that replaces an amino
acid residue conserved among short-chain alcohol dehydroge-
nases causes destabilization of the enzyme and its inactivation.
Physiological tests revealed delayed resensitization of rod and,
even more profoundly, cone photoreceptor cells following full
bleaches. Cones showed a biphasic recovery with an initial
rapid component and an elevated final threshold. It is unclear
whether this observation is related to a recently reported com-
plex between the photoisomerization protein RGR and 11-cis-
RDH (30). Under these conditions, RGR could be involved in
photoregeneration that support cones, whereas rods are satu-
rated. At lower bleaching levels, normal rod recovery is ob-
served following 0.5% bleaching and abnormal slow recovery
following bleaches in the 2–12% range. These intermediate
bleaches showed a rapid partial recovery of rods with a tran-
sitory plateau. Pathways in addition to 11-cis-RDH likely pro-
vide 11-cis-retinal for both rods and cones and can maintain
normal kinetics of visual recovery, but only under certain con-
straints they are less efficient for cone than rod function (22,
62). Additional biochemical assays using specifically [3H]la-
beled dinucleotides pointed out the existence of an alternative
oxidizing system for the production of 11-cis-retinal. The 11-
cis-rdh/ mice are an interesting model of fundus albipunc-
tatus; however, they show some striking differences. The elec-
troretinograms show only a delay in dark adaptation after
50% bleach (23). Unfortunately, no biochemical data are
available yet for human donor eyes with this disease to analyze
whether there is any abnormal accumulation of retinoids in
these patients, as we observed in mice. The most important
observation from both animal and human studies on 11-cis-
RDH defects is that there are alternative mechanisms (en-
zymes) present that allow production of 11-cis-retinal. How-
ever, these enzymes have not been yet characterized at the
molecular level.
At high bleaching levels, RGR may be one of the alternative
pathways playing an important role in production of 11-cis-
retinal. Because in this reaction all-trans-retinal is directly
converted to 11-cis-retinal, no oxidation step is needed. This
route could support an alternative method of 11-cis-retinal
generation, but only if light is continuously present. In the case
of a pulse of illumination, this pathway is not likely to be
involved; however, 11-cis-rdh/ mice submitted to flash
were still able to regenerate rhodopsin. Therefore, another
alternative oxidoreductase must be present.
Characterization of a Novel Dehydrogenase Involved in Oxi-
dation of 11-cis-Retinol—cis-RDH activity in 11-cis-rdh/
RPE preparations is pro-S-[4-3H]NADH-dependent. This pro-
S-[4-3H]NADH dependence and retinoid substrate specificity
are also similar to those reported in bovine RPE microsomes, in
which 13-cis-retinal is best utilized (18). In 11-cis-rdh/ RPE
microsomes, activities for 9-cis-retinal, 11-cis-retinal, and 13-
cis-retinal can also be observed with pro-S-[4-3H]NADH, al-
though they are very minor compared with those in 11-cis-
rdh/ animals. In contrast, 11-cis-rdh/ mice are clearly
able to reduce 9-cis-retinal and 11-cis-retinal with pro-S-[4-
3H]NADPH at an increased rate compared with pro-S-[4-
3H]NADH. However, this is not observed for 13-cis-retinal with
pro-S-[4-3H]NADPH. In addition, there are trace but detecta-
ble activities with pro-R-[4-3H]NAD(P)H and all four retinal
isomers, and no differences in activity can be distinguished
between the 11-cis-rdh/ and 11-cis-rdh/ animals.
These lower activities toward 9-cis-retinol and 11-cis-retinol
activities in 11-cis-rdh/ animals are probably sufficient to
maintain the retinal retinoid flow but with less efficiency (22,
23). Although bovine RPE cytosol has been carefully prepared
by ultracentrifugation in the presence of Mg2 and Ca2 and
filtration through a 0.22 m filter, there is only very residual
activity (Fig. 8) detected with pro-S-[4-3H]NADH, showing the
same retinoid substrate specificity as in RPE microsomes (18).
These results suggest that the soluble enzymes are not likely to
be responsible for a significant contribution to 11-cis-retinol
oxidation in the RPE cytosol. All-trans-RDH activity is detected
in both 11-cis-rdh/ and 11-cis-rdh/ RPE membranes in
a pro-S-[4-3H]NADPH-dependent manner, and are most likely
a result of ROS contamination during the RPE microsomal
preparations (18, 63).
As the chromophore regeneration capacity in 11-cis-rdh/
mice is only mildly affected, it was rather surprising to find
that 11-cis-retinol oxidation was reduced at least 5-fold in the
RPE of these animals. This could be easily explained if other
steps in the retinoid cycle are rate-limiting. Interestingly, re-
duction of all-trans-retinal in ROS has been proposed to be the
rate-limiting step in the retinoid cycle (31, 32). This is also
supported by the fact that disruption of 11-cis-RDH produced
only a modest accumulation of cis-retinols after an intense
bleach (Fig. 4); in 11-cis-rdh/ mice, the rate of 11-cis-retinol
oxidation is comparable to other rate-limiting steps. An alter-
native explanation might be that the procedure employed to
isolate RPE membranes results in reduced activity of the al-
ternative enzyme.
Napoli and co-workers (64) have reported on the cloning of a
member of the short-chain alcohol dehydrogenase family
termed CRAD2. CRAD2 has steroid 3- and 17-dehydrogenase
and cis/trans-retinol catalytic activities. Although the enzyme
is expressed predominantly in liver, CRAD2 transcripts were
also found in the RPE (64). Our intensive characterization of
the alternative enzyme involved in the oxidation reaction of
11-cis-retinol is very useful in eliminating CRAD2 as a major
contributor to the 11-cis-RDH activity in the RPE because in
contrast to the NAD-preferring CRAD2 (10-fold preference),
the alternative 11-cis-RDH prefers NADP.
In summary, these results provide a detailed characteriza-
tion of a mouse model of the human disease fundus albipunc-
tatus. They point out the importance of 11-cis-RDH in keeping
the balance between different components of the retinoid cycle.
Lack of 11-cis-RDH perturbs these relationships and leads to
accumulation of cis-retiniods, and in particular, it is likely the
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first vertebrate model system in which a 13-cis-retinol isomer
is present in high concentrations. This finding implies indi-
rectly that the presence of 11-cis-RDH somehow impacts the
removal of this isomer in wild-type mice. The analysis of 11-
cis-rdh/ mice is also convenient for the characterization of
the RDH that is responsible for an alternative pathway of
11-cis-retinal production. Cloning and further characterization
of this enzyme and double knockout mice for both dehydroge-
nases should be very helpful in understanding the individual
contributions of these dehydrogenases in the retinoid cycle.
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